Effects of the German skin cancer screening programme on melanoma incidence and indicators of disease severity

British Journal of Dermatology

Volumn 175, Issue 5, 2016, Pages 912-919

  Trautmann, F ^a,b   Meier, F ^c   Seidler, A ^a   Schmitt, J ^a,b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b NATIONAL CENTER FOR TUMOR DISEASES NCT   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER SCREENING; CHILD; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DISTANT METASTASIS; FEMALE; GERMANY; HEALTH CARE UTILIZATION; HUMAN; INFANT; LONGITUDINAL STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA SKIN CANCER; MIDDLE AGED; NEWBORN; NON MELANOMA SKIN CANCER; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; SCHOOL CHILD; VERY ELDERLY; YOUNG ADULT; EARLY CANCER DIAGNOSIS; INCIDENCE; MELANOMA; METASTASIS; SKIN NEOPLASMS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; GERMANY; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84992573855     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.14758     Document Type: Article

References (30)

1. Kaatsch P, Spix C, Hentschel S et al. Cancer in Germany 2009/2010. Available at: www.gekid.de/Doc/kid2014_english.pdf (last accessed 20 July 2016).
2. Anker M, Bartoszak B, Draheim S et al. Krebs in Sachsen. Inzidenz und Mortalität 2008–2009. Available at: http://www.berlin.de/gkr/_assets/krebs_in_sachsen_2008_2009.pdf (last accessed 20 July 2016).
3. Eisemann N, Jansen L, Holleczek B et al. Up-to-date results on survival of patients with melanoma in Germany. Br J Dermatol 2012; 167:606–12.
4. Grobe TG, Heller G, Szecsenyi J. BARMER GEK Arztreport. Available at: https://www.aqua-institut.de/aqua/upload/CONTENT/Projekte/Gesundheitsberichterstattung/Barmer_Arztreport-2014.pdf (last accessed 20 July 2016).
5. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001; 344:975–83.
6. Markovic SN, Erickson LA, Rao RD et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 2007; 82:364–80.
7. Bundesministerium für Gesundheit (German Ministry of Health). Bekanntmachung eines Beschlusses des Gemeinsamen bundesausschusses über eine Änderung der Krebsfrüherkennungs-Richtlinien: Hautkrebs-Screening. BAnz 2008; 37:871.
8. Geller AC, Greinert R, Sinclair C et al. A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009). Cancer Epidemiol 2010; 34:355–8.
9. Breitbart EW, Waldmann A, Nolte S et al. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol 2012; 66:201–11.
10. Becher H, Kuhn K, Hoffmann W et al. ‘Einführung Hautkrebs Screening’ – Letter to the Federal Ministry of Health. Available at: http://dgepi.de/fileadmin/pdf/stellungnahmen/Hautkrebs-Screening_Schreiben_der_gmds_DGEpi_20-04-2008.pdf (last accessed 20 July 2016).
11. Curiel-Lewandrowski C, Chen SC, Swetter SM. Screening and prevention measures for melanoma: is there a survival advantage? Curr Oncol Rep 2012; 14:458–67.
12. Choudhury K, Volkmer B, Greinert R et al. Effectiveness of skin cancer screening programmes. Br J Dermatol 2012; 167(Suppl. 2):94–8.
13. Veit C, Lüken F, Melsheimer O. Evaluation der Screeninguntersuchungen auf Hautkrebs gemäß Krebsfrüherkennungs-Richtlinie des Gemeinsamen Bundesausschusses, Abschlussbericht 2009–2010. Gemeinsamer Bundesausschuss 2015. Available at: https://www.g-ba.de/downloads/17-98-3907/2015-03-11_BQS_HKS-Abschlussbericht-2009-2010.pdf (last accessed 20 July 2016).
14. Aitken JF, Elwood M, Baade PD et al. Clinical whole-body skin examination reduces the incidence of thick melanomas. Int J Cancer 2010; 126:450–8.
15. Aitken JF, Elwood JM, Lowe JB et al. A randomised trial of population screening for melanoma. J Med Screen 2002; 9:33–7.
16. Terushkin V, Halpern AC. Melanoma early detection. Hematol Oncol Clin North Am 2009; 23:481–500.
17. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013; 310:2191–4.
18. Working Group for the Survey and Utilization of Secondary Data (AGENS). Good practice in secondary data analysis: revision after fundamental reworking. Available at: http://dgepi.de/fileadmin/pdf/leitlinien/gps-version2-final_ENG.pdf (last accessed 20 July 2016).
19. Sozialgesetzbuch Fünftes Buch. Gesetzliche Krankenversicherung. Available at: http://www.gesetze-im-internet.de/sgb_5/__87.html (last accessed 20 July 2016).
20. National Association of Statutory Health Insurance Physicians of Germany (Kassenärztliche Bundesvereinigung). Einheitlicher Bewertungsmaßstab für ärztliche Leistungen. Available at: http://applications.kbv.de/ebm/EBMGesamt.htm (last accessed 20 July 2016).
21. World Health Organization. International Classification of Diseases and Related Health Problems 10th Revision. Available at: http://apps.who.int/classifications/icd10/browse/2015/en (last accessed 20 July 2016).
22. German Institute of Medical Documentation and Information. ICD-10-WHO. Available at: https://www.dimdi.de/static/en/klassi/icd-10-who/index.htm (last accessed 20 July 2016).
23. Consortium of Scientific Medical Compartment Companies. Malignes Melanom; Diagnostik, Therapie und Nachsorge. Available at: http://www.awmf.org/leitlinien/detail/ll/032-024OL.html (last accessed 20 July 2016).
24. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2016. Available at: http://www.whocc.no/atc_ddd_index/ (last accessed 20 July 2016).
25. Eurostat. Revision of the European Standard Population. Report of Eurostat's task force – 2013 edition. Available at: http://ec.europa.eu/eurostat/documents/3859598/5926869/KS-RA-13-028-EN.PDF/e713fa79-1add-44e8-b23d-5e8fa09b3f8f (last accessed 20 July 2016).
26. Enthaler N. Sönnichsen A [Effectiveness of melanoma screening]. Z Allg Med 2013; 89:215–20 (in German).
27. Geller AC, Zhang Z, Sober AJ et al. The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985–1999. J Am Acad Dermatol 2003; 48:34–41.
28. Markovic SN, Erickson LA, Rao RD et al. Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc 2007; 82:490–513.
29. Federal Statistical Offices of Germany. Database of the Census 2011. Available at: https://ergebnisse.zensus2011.de (last accessed 20 July 2016).
30. Faries MB, Steen S, Ye X et al. Late recurrence in melanoma: clinical implications of lost dormancy. J Am Coll Surg 2013; 217:27–34.